Chromosome 22q11.2 Deletion Syndrome | CHOP Research Institute

Researchers Explore Connection Between Mitochondrial Function and Schizophrenia in 22q11DS

Published on

Jul 19, 2021

Mitochondrial Function and Schizophrenia in 22q11DS

CHOP and Penn researchers find connection between mitochondrial function and mental illness in patients with a rare genetic disorder.

Sullivan Laboratory

The Sullivan Lab has a broad interest in immune dysfunction. This can underlie susceptibility to infections and autoimmunity and inflammation. The investigators in the lab use cutting-edge approaches to investigate cause in individual patients and to look at population-wide causes of disease.

Kathleen E. Sullivan, MD, PhD

Dr. Sullivan's research focuses on new and rare immunodeficiencies. She has a long-standing interest in one of the most common of the primary immunodeficiencies – chromosome 22q11.2 deletion syndrome. She also investigates common variable immunodeficiency, as well as the genetics and epigenetics of systemic lupus erythematosus.

E-mail:

sullivank [at] chop.edu

In the News: ONC Award, Vision and Concussions, Raising 22q11.2 Deletion Syndrome Awareness

Published on

Jul 22, 2016

in Cornerstone Blog

Our weekly installment of In the News keeps an eye out for the latest research happenings. This week we're excited to report on a second award for an innovative technology solution to access, filter, and harness emerging disease updates.